stockrowProQR Therapeutics N.V. (PRQR) vs Entrada Therapeutics, Inc. (TRDA)
- ProQR Therapeutics N.V. PRQR 1.35 +1.50%
- Entrada Therapeutics, Inc. TRDA 4.89 +7.47%
ProQR Therapeutics N.V. and Entrada Therapeutics, Inc. are both Biotechnology companies. ProQR Therapeutics N.V. and Entrada Therapeutics, Inc. are of similar size ($191.5M and $190.5M). ProQR Therapeutics N.V. grew revenue faster over the last twelve months: 19.7% against −93.5%. ProQR Therapeutics N.V. has the higher net margin (−228.7% vs −4,058.0%) and the higher return on invested capital (0.00% vs −2,009.0%). Across the 16 metrics below, ProQR Therapeutics N.V. leads on 12 and Entrada Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | PRQR | TRDA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (233.33%) | (4,303.82%) | 0.00% |
| Net margin | (228.71%) | (4,057.98%) | 0.00% |
| Free cash flow margin | (267.36%) | (3,428.06%) | 0.00% |
| Return on equity | (58.29%) | (59.88%) | (51.96%) |
| Return on assets | (31.53%) | (47.48%) | (46.06%) |
| Return on invested capital | 0.00% | (2,008.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack